chalcone has been researched along with Degenerative Diseases, Central Nervous System in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, R; Han, C; Li, B; Liu, Y | 1 |
| Cai, R; Chen, D; Deng, F; Li, X; Liu, J; Ren, Z; Zhang, A | 1 |
2 other study(ies) available for chalcone and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Rational design, synthesis and activities of hydroxylated chalcones as highly potent dual functional agents against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Chalcone; Chalcones; Cholinesterase Inhibitors; Drug Design; Molecular Docking Simulation; Neurodegenerative Diseases; Peptide Fragments; Structure-Activity Relationship | 2022 |
Simultaneous Study of Anti-Ferroptosis and Antioxidant Mechanisms of Butein and (
Topics: Antioxidants; Bone Marrow Cells; Chalcone; Chalcones; Chromatography, High Pressure Liquid; Ferroptosis; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Molecular Structure; Neurodegenerative Diseases; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2020 |